MUNICH, Germany—Wacker CEO Christian Hartel said that Wacker Chemie A.G. had a "challenging" 2024 thanks to various market factors. But looking forward to 2025, he expects all business groups to grow, even in the face of economic headwinds.
Group sales went down by 11 percent in 2024, according to Hartel, thanks to lower volume and a "persistently weak" chemical market, dropping from $6.97 billion to $6.21 billion. EBITDA also decreased by 7 percent, he said, going from $897 million in 2023, to $831 million in 2024.
"Despite headwinds, our chemical divisions achieved sales at the previous year's level and earnings in total in these divisions even exceeded the prior-year figure," Hartel said during Wacker's annual report meeting March 12. "Sales and earnings in our biotech division were up year over year.
"It was only the polysilicon division that painted a mixed picture. Our solar-grade polysilicon business has declined primarily due to excess capacity in China."
Wacker Chief Financial Officer Tobias Ohler said that the lower sales mostly came from softness in the company's polysilicon division, where sales dropped 41 percent from 2023, going from $1.72 billion to $1.59 billion. Combined with a 40-percent decrease in EBITDA, the sales drop represented a sizable financial downturn for the polysilicone sector. The report pointed to "lower prices and volumes for solar-grade polysilicon" as well as high energy prices throughout Germany as reason for the unit's lagging performance.
"Compared to various regions, (energy) costs are high in Germany," Ohler said. "In contrast, savings from ongoing efficiency measures positively influenced earnings, and we won't be easing off in 2025."